Unparalleled data wealth powers the CE-marked analysis engines behind One Drop’s health forecasting and predictive capabilities
Brighter AB (publ), acting by its subsidiary Brighter Software Trading L.L.C, has entered into a commercial partnership with Prime Healthcare Group in Dubai regarding the recommendation and sale of Brighter's diabetes solution Actiste® (the "Actiste service") in the UAE.
#insulin pen
Virtual chronic care company Vida Health today announced the hiring of Jason Parrott as Senior VP of Enterprise Growth and Partnerships. Parrott, who is joining Vida from Boeing — a Vida client — will lead strategic partnerships.
Successful measurements of interstitial glucose are a key component in providing effective care for patients with diabetes. Recently, there has been significant interest in using neural networks to forecast future glucose values from interstitial measurements collected by continuous glucose monitors (CGMs). While prediction accuracy continues to improve, in this work we investigated the effect of physiological sensor location on neural network blood glucose forecasting.
#cgm
Continuous glucose monitoring systems (CGMs) play an important role in the management of T1D, but their accuracy may reduce during rapid glucose excursions. The aim of study was to assess the accuracy of recent rt-CGMs available in Italy, in subjects with T1D during 2 sessions of physical activity: moderate continuous (CON) and interval exercise (IE).
#cgm
Abbott has increased its dividend payout for 49 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends annually for at least 25 consecutive years.
Flash glucose monitoring (FGM) systems can reduce glycemic variability and facilitate blood glucose management within the target range. However, in critically ill patients, only small (n < 30) studies have examined the accuracy of FGM and none have assessed the stability of FGM accuracy. We evaluated the accuracy and stability of FGM in critically ill patients.
#cgm
Brighter AB (publ) announces today that its subsidiary Brighter Software Trading LLC has signed a commercial partnership with Al Zahra Hospital in Dubai regarding the implementation of Brighter's diabetes solution Actiste® (the "Actiste service").
#insulin pen
Brighter AB (Publ) announced today that CFO Ann Zetterberg has chosen to leave Brighter for new opportunities. Ann is stepping down from her active role as CFO but will continue in an advisory capacity until August 16, 2021 to ensure a smooth transition.
Available early next year across iOS and Android platforms, FitScan will enable its users to privately check, track, accurately assess overall wellness and predict potential health risks — all from their smartphone. FitScan’s Body Assessment scan will combine innovative technology and state of the art image processing techniques that returns over ten unique insights such as body circumference, body composition, and risk indicators for obesity and type-2 diabetes. The innovative software will launch in early 2022.
#product & service
#mobile app